<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Prescription Drugs &#187; Ciprofloxacin</title>
	<atom:link href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/feed" rel="self" type="application/rss+xml" />
	<link>http://www.prescriptiondrugs2go.com</link>
	<description>Popoular Prescription Drugs Latest News</description>
	<lastBuildDate>Tue, 07 Sep 2010 07:40:08 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Molecular characterization of antimicrobial resistance in non-typhoidal salmonellae associated with systemic manifestations from Pondicherry, Bangalore and Mangalore in India.</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/molecular-characterization-of-antimicrobial-resistance-in-non-typhoidal-salmonellae-associated-with-systemic-manifestations-from-pondicherry-bangalore-and-mangalore-in-india-2.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/molecular-characterization-of-antimicrobial-resistance-in-non-typhoidal-salmonellae-associated-with-systemic-manifestations-from-pondicherry-bangalore-and-mangalore-in-india-2.html#comments</comments>
		<pubDate>Mon, 06 Sep 2010 02:27:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Ciprofloxacin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/molecular-characterization-of-antimicrobial-resistance-in-non-typhoidal-salmonellae-associated-with-systemic-manifestations-from-pondicherry-bangalore-and-mangalore-in-india-2.ht</guid>
		<description><![CDATA[Authors: Menezes GA, Khan MA, Harish BN, Parija SC, Goessens W, Vidyalakshmi K, Baliga S, Hays JP
    Extended-spectrum cephalosporins and fluoroquinolones are essential antimicrobials for treating invasive salmonellosis, though emerging resistance to these antimicrobials is of growing concern, especially within India. Therefore, a study was conducted to characterize the antimicrobial susceptibility phenotypes, types of extended spectrum beta-lactamase (ESBL) genes plasmids, and serological relationships of 21 non-typhoidal salmonellae isolated from patients who attended 3 different hospitals in India during the years 2006-2008. The isolates were cultured from stool, ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/molecular-characterization-of-antimicrobial-resistance-in-non-typhoidal-salmonellae-associated-with-systemic-manifestations-from-pondicherry-bangalore-and-mangalore-in-india-2.html">Molecular characterization of antimicrobial resistance in non-typhoidal salmonellae associated with systemic manifestations from Pondicherry, Bangalore and Mangalore in India.</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Authors: Menezes GA, Khan MA, Harish BN, Parija SC, Goessens W, Vidyalakshmi K, Baliga S, Hays JP<br />
    Extended-spectrum cephalosporins and fluoroquinolones are essential antimicrobials for treating invasive salmonellosis, though emerging resistance to these antimicrobials is of growing concern, especially within India. Therefore, a study was conducted to characterize the antimicrobial susceptibility phenotypes, types of extended spectrum beta-lactamase (ESBL) genes plasmids, and serological relationships of 21 non-typhoidal salmonellae isolated from patients who attended 3 different hospitals in India during the years 2006-2008. The isolates were cultured from stool, blood, and cerebrospinal fluid (CSF) samples obtained from patients presenting with diarrhoea and accompanying systemic mani&#8230;
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/molecular-characterization-of-antimicrobial-resistance-in-non-typhoidal-salmonellae-associated-with-systemic-manifestations-from-pondicherry-bangalore-and-mangalore-in-india-2.html">Molecular characterization of antimicrobial resistance in non-typhoidal salmonellae associated with systemic manifestations from Pondicherry, Bangalore and Mangalore in India.</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/molecular-characterization-of-antimicrobial-resistance-in-non-typhoidal-salmonellae-associated-with-systemic-manifestations-from-pondicherry-bangalore-and-mangalore-in-india-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Comparative biogeography of Chromobacterium from the neotropics.</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/comparative-biogeography-of-chromobacterium-from-the-neotropics-2.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/comparative-biogeography-of-chromobacterium-from-the-neotropics-2.html#comments</comments>
		<pubDate>Thu, 02 Sep 2010 07:43:32 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Ciprofloxacin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/comparative-biogeography-of-chromobacterium-from-the-neotropics-2.html</guid>
		<description><![CDATA[Authors: Lima-Bittencourt CI, Costa PS, Hollatz C, Raposeiras R, Santos FR, Chartone-Souza E, Nascimento AM
    The genus Chromobacterium encompasses free-living Gram-negative bacteria. Until 2007, the genus consisted of only one species but six species are now recognized. Chromobacterium violaceum is the type species of the genus and is commonly found in soil and water in tropical and sub-tropical regions. We have investigated a collection of 111 isolates displaying violet pigmentation from undisturbed aquatic and soil environments from Brazilian Cerrado ecosystem. The 16S rRNA gene phylogeny revealed that ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/comparative-biogeography-of-chromobacterium-from-the-neotropics-2.html">Comparative biogeography of Chromobacterium from the neotropics.</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Authors: Lima-Bittencourt CI, Costa PS, Hollatz C, Raposeiras R, Santos FR, Chartone-Souza E, Nascimento AM<br />
    The genus Chromobacterium encompasses free-living Gram-negative bacteria. Until 2007, the genus consisted of only one species but six species are now recognized. Chromobacterium violaceum is the type species of the genus and is commonly found in soil and water in tropical and sub-tropical regions. We have investigated a collection of 111 isolates displaying violet pigmentation from undisturbed aquatic and soil environments from Brazilian Cerrado ecosystem. The 16S rRNA gene phylogeny revealed that all isolates were allocated in a monophyletic cluster inside the Chromobacterium genus and formed few clusters related most closely with Chromobacterium piscinae. The two sets of isolat&#8230;
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/comparative-biogeography-of-chromobacterium-from-the-neotropics-2.html">Comparative biogeography of Chromobacterium from the neotropics.</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/comparative-biogeography-of-chromobacterium-from-the-neotropics-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Review: Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/review-best-drug-treatment-for-multidrug-resistant-and-extensively-drug-resistant-tuberculosis-2.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/review-best-drug-treatment-for-multidrug-resistant-and-extensively-drug-resistant-tuberculosis-2.html#comments</comments>
		<pubDate>Fri, 27 Aug 2010 13:00:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Ciprofloxacin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/review-best-drug-treatment-for-multidrug-resistant-and-extensively-drug-resistant-tuberculosis-2.html</guid>
		<description><![CDATA[Source: Lancet Infectious Diseases
Area: News
 In this review, the authors discuss the evidence that rational use of antituberculosis drugs can treat multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis. The following drugs groups are covered:
 &#160;
 .&#160;Group one- first-line antituberculosis drugs: isoniazid, rifampicin and others rifamycins, pyrazinamide, ethambutol.
 &#160;
 .&#160;Group two- fluoroquinolones: Ciprofloxacin, ofloxacin, levofloxacin, and moxifloxacin.
 &#160;
 .&#160;Group three- injectable antituberculosis drugs: aminoglycosides (streptomycin, kanamycin, and amikacin) and the polypeptides (capreomycin and viomycin)
 &#160;
 .&#160;Group four- second-line antituberculosis drugs:&#160; thioamides (ethionamide and protionamide), cycloser&#8230;

MedWorm Message: Register for MedMatcha, MedWorm&#8217;s medical ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/review-best-drug-treatment-for-multidrug-resistant-and-extensively-drug-resistant-tuberculosis-2.html">Review: Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Source: Lancet Infectious Diseases<br />
Area: News<br />
 In this review, the authors discuss the evidence that rational use of antituberculosis drugs can treat multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis. The following drugs groups are covered:<br />
 &nbsp;<br />
 .&nbsp;Group one- first-line antituberculosis drugs: isoniazid, rifampicin and others rifamycins, pyrazinamide, ethambutol.<br />
 &nbsp;<br />
 .&nbsp;Group two- fluoroquinolones: <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin">Ciprofloxacin</a>, ofloxacin, levofloxacin, and moxifloxacin.<br />
 &nbsp;<br />
 .&nbsp;Group three- injectable antituberculosis drugs: aminoglycosides (streptomycin, kanamycin, and amikacin) and the polypeptides (capreomycin and viomycin)<br />
 &nbsp;<br />
 .&nbsp;Group four- second-line antituberculosis drugs:&nbsp; thioamides (ethionamide and protionamide), cycloser&#8230;
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/review-best-drug-treatment-for-multidrug-resistant-and-extensively-drug-resistant-tuberculosis-2.html">Review: Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/review-best-drug-treatment-for-multidrug-resistant-and-extensively-drug-resistant-tuberculosis-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Species-Dependent Degradation of Ciprofloxacin in a Membrane Anodic Fenton System</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/species-dependent-degradation-of-ciprofloxacin-in-a-membrane-anodic-fenton-system-2.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/species-dependent-degradation-of-ciprofloxacin-in-a-membrane-anodic-fenton-system-2.html#comments</comments>
		<pubDate>Thu, 26 Aug 2010 07:40:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Ciprofloxacin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/species-dependent-degradation-of-ciprofloxacin-in-a-membrane-anodic-fenton-system-2.html</guid>
		<description><![CDATA[Journal of Agricultural and Food Chemistry, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable). (Source: Journal of Agricultural and Food Chemistry)
Species-Dependent Degradation of Ciprofloxacin in a Membrane Anodic Fenton System is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/species-dependent-degradation-of-ciprofloxacin-in-a-membrane-anodic-fenton-system-2.html">Species-Dependent Degradation of Ciprofloxacin in a Membrane Anodic Fenton System</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Journal of Agricultural and Food Chemistry, Volume 0, Issue 0, Articles ASAP (As Soon As Publishable). (Source: Journal of Agricultural and Food Chemistry)</p>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/species-dependent-degradation-of-ciprofloxacin-in-a-membrane-anodic-fenton-system-2.html">Species-Dependent Degradation of Ciprofloxacin in a Membrane Anodic Fenton System</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/species-dependent-degradation-of-ciprofloxacin-in-a-membrane-anodic-fenton-system-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Small RCT: Cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection of no benefit in children with cystic fibrosis?</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/small-rct-cycled-antibiotic-prophylaxis-to-prevent-initial-pseudomonas-aeruginosa-infection-of-no-benefit-in-children-with-cystic-fibrosis-2.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/small-rct-cycled-antibiotic-prophylaxis-to-prevent-initial-pseudomonas-aeruginosa-infection-of-no-benefit-in-children-with-cystic-fibrosis-2.html#comments</comments>
		<pubDate>Thu, 26 Aug 2010 07:40:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Ciprofloxacin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/small-rct-cycled-antibiotic-prophylaxis-to-prevent-initial-pseudomonas-aeruginosa-infection-of-no-benefit-in-children-with-cystic-fibrosis-2.html</guid>
		<description><![CDATA[Source: Thorax
Area: News
 According to the results of this small randomised controlled trial (RCT), prophylaxis with Ciprofloxacin and inhaled colistin does not reduce the risk of Pseudomonas aeruginosa (P aeruginosa) infection in children with cystic fibrosis (CF).
 &#160;
 The authors note that children with CF are at a high risk of acquiring pulmonary infections with P aeruginosa &#8211; this is hard to eradicate once established in the airways and is associated with irreversible pulmonary damage.&#160; Prophylactic treatment appeared to have a beneficial effect in previous retrospective studies; the purpose of ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/small-rct-cycled-antibiotic-prophylaxis-to-prevent-initial-pseudomonas-aeruginosa-infection-of-no-benefit-in-children-with-cystic-fibrosis-2.html">Small RCT: Cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection of no benefit in children with cystic fibrosis?</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Source: Thorax<br />
Area: News<br />
 According to the results of this small randomised controlled trial (RCT), prophylaxis with <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin">Ciprofloxacin</a> and inhaled colistin does not reduce the risk of Pseudomonas aeruginosa (P aeruginosa) infection in children with cystic fibrosis (CF).<br />
 &nbsp;<br />
 The authors note that children with CF are at a high risk of acquiring pulmonary infections with P aeruginosa &#8211; this is hard to eradicate once established in the airways and is associated with irreversible pulmonary damage.&nbsp; Prophylactic treatment appeared to have a beneficial effect in previous retrospective studies; the purpose of the current study was to evaluate this prospectively.<br />
 &nbsp;<br />
 The study involved 65 children with CF who did not have P aeruginosa infection.&nbsp; They were randomised to triple&#8230;</p>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/small-rct-cycled-antibiotic-prophylaxis-to-prevent-initial-pseudomonas-aeruginosa-infection-of-no-benefit-in-children-with-cystic-fibrosis-2.html">Small RCT: Cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection of no benefit in children with cystic fibrosis?</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/small-rct-cycled-antibiotic-prophylaxis-to-prevent-initial-pseudomonas-aeruginosa-infection-of-no-benefit-in-children-with-cystic-fibrosis-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CIPROFLOXACIN (Ciprofloxacin Hydrochloride) Tablet CIPROFLOXACIN (Ciprofloxacin Hydrochloride) Tablet, Film Coated [Physicians Total Care, Inc.]</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ciprofloxacin-ciprofloxacin-hydrochloride-tablet-ciprofloxacin-ciprofloxacin-hydrochloride-tablet-film-coated-physicians-total-care-inc-4.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ciprofloxacin-ciprofloxacin-hydrochloride-tablet-ciprofloxacin-ciprofloxacin-hydrochloride-tablet-film-coated-physicians-total-care-inc-4.html#comments</comments>
		<pubDate>Thu, 26 Aug 2010 07:40:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Ciprofloxacin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ciprofloxacin-ciprofloxacin-hydrochloride-tablet-ciprofloxacin-ciprofloxacin-hydrochloride-tablet-film-coated-physicians-total-care-inc-4.html</guid>
		<description><![CDATA[Updated Date: Aug 24, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
CIPROFLOXACIN (Ciprofloxacin Hydrochloride) Tablet CIPROFLOXACIN (Ciprofloxacin Hydrochloride) Tablet, Film Coated [Physicians Total Care, Inc.] is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ciprofloxacin-ciprofloxacin-hydrochloride-tablet-ciprofloxacin-ciprofloxacin-hydrochloride-tablet-film-coated-physicians-total-care-inc-4.html">CIPROFLOXACIN (Ciprofloxacin Hydrochloride) Tablet CIPROFLOXACIN (Ciprofloxacin Hydrochloride) Tablet, Film Coated [Physicians Total Care, Inc.]</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Updated Date: Aug 24, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))</p>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ciprofloxacin-ciprofloxacin-hydrochloride-tablet-ciprofloxacin-ciprofloxacin-hydrochloride-tablet-film-coated-physicians-total-care-inc-4.html">CIPROFLOXACIN (Ciprofloxacin Hydrochloride) Tablet CIPROFLOXACIN (Ciprofloxacin Hydrochloride) Tablet, Film Coated [Physicians Total Care, Inc.]</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ciprofloxacin-ciprofloxacin-hydrochloride-tablet-ciprofloxacin-ciprofloxacin-hydrochloride-tablet-film-coated-physicians-total-care-inc-4.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ciprofloxacin: Mania in an elderly patient: case report</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ciprofloxacin-mania-in-an-elderly-patient-case-report-2.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ciprofloxacin-mania-in-an-elderly-patient-case-report-2.html#comments</comments>
		<pubDate>Thu, 26 Aug 2010 07:40:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Ciprofloxacin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ciprofloxacin-mania-in-an-elderly-patient-case-report-2.html</guid>
		<description><![CDATA[(Source: Reactions)
Ciprofloxacin: Mania in an elderly patient: case report is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ciprofloxacin-mania-in-an-elderly-patient-case-report-2.html">Ciprofloxacin: Mania in an elderly patient: case report</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>(Source: Reactions)</p>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ciprofloxacin-mania-in-an-elderly-patient-case-report-2.html">Ciprofloxacin: Mania in an elderly patient: case report</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ciprofloxacin-mania-in-an-elderly-patient-case-report-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Detection of inducible clindamycin resistance among Staphylococcal isolates from different clinical specimens in western India</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/detection-of-inducible-clindamycin-resistance-among-staphylococcal-isolates-from-different-clinical-specimens-in-western-india-2.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/detection-of-inducible-clindamycin-resistance-among-staphylococcal-isolates-from-different-clinical-specimens-in-western-india-2.html#comments</comments>
		<pubDate>Thu, 26 Aug 2010 07:40:19 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Ciprofloxacin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/detection-of-inducible-clindamycin-resistance-among-staphylococcal-isolates-from-different-clinical-specimens-in-western-india-2.html</guid>
		<description><![CDATA[Conclusions: Fifty percent of Staphylococcal spp. were ER among which 23.48&#x25; were iMLS B phenotypes. Eighty-seven per cent of iMLS B phenotypes were observed to be methicillin-resistant. The high frequency of methicillin resistance isolates (87.12&#x25;) with in vitro inducible clindamycin resistance at our institute raises concern of clindamycin treatment failures with methicillin-resistant infections. So we recommend that microbiology laboratories should include the D-test for inducible resistance to clindamycin in the routine antibiotic susceptibility testing. (Source: Journal of Postgraduate Medicine)

MedWorm Message: Register for MedMatcha, MedWorm&#8217;s medical advertising network, and receive $5 ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/detection-of-inducible-clindamycin-resistance-among-staphylococcal-isolates-from-different-clinical-specimens-in-western-india-2.html">Detection of inducible clindamycin resistance among Staphylococcal isolates from different clinical specimens in western India</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Conclusions: Fifty percent of Staphylococcal spp. were ER among which 23.48&#x25; were iMLS B phenotypes. Eighty-seven per cent of iMLS B phenotypes were observed to be methicillin-resistant. The high frequency of methicillin resistance isolates (87.12&#x25;) with in vitro inducible clindamycin resistance at our institute raises concern of clindamycin treatment failures with methicillin-resistant infections. So we recommend that microbiology laboratories should include the D-test for inducible resistance to clindamycin in the routine antibiotic susceptibility testing. (Source: Journal of Postgraduate Medicine)
<div>
<p><b><i>MedWorm Message:</i></b> Register for <b><a href="http://www.medmatcha.com" target="_self">MedMatcha, MedWorm&#8217;s medical advertising network</a></b>, and receive $5 free advertising.</p>
</div>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/detection-of-inducible-clindamycin-resistance-among-staphylococcal-isolates-from-different-clinical-specimens-in-western-india-2.html">Detection of inducible clindamycin resistance among Staphylococcal isolates from different clinical specimens in western India</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/detection-of-inducible-clindamycin-resistance-among-staphylococcal-isolates-from-different-clinical-specimens-in-western-india-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ileal pouch dysfunction</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ileal-pouch-dysfunction-2.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ileal-pouch-dysfunction-2.html#comments</comments>
		<pubDate>Thu, 26 Aug 2010 07:40:18 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Ciprofloxacin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ileal-pouch-dysfunction-2.html</guid>
		<description><![CDATA[Abstract&#160;&#160;The causes of pouch dysfunction are inflammatory, non-inflammatory and iatrogenic. The most common long-term complication
 is pouchitis. Diagnosis should be based on clinical symptoms, endoscopic appearance and histologic findings. Ciprofloxacin
 and metronidazole are the treatment of choice for pouchitis. Fistulae and perianal abscesses should be suspected to be an
 expression of misdiagnosed Crohn&#8217;s disease. Strictures are confronted by endoscopic balloon dilatation. Patients who will
 be refractory to all forms of medical treatment should have surgical treatment such as faecal diversion or pouch revision.
	Content Type Journal ArticleDOI 10.1007/s10151-010-0630-zAuthors
		V. N. Papadopoulos, 1st ...<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ileal-pouch-dysfunction-2.html">Ileal pouch dysfunction</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Abstract&nbsp;&nbsp;The causes of pouch dysfunction are inflammatory, non-inflammatory and iatrogenic. The most common long-term complication<br />
 is pouchitis. Diagnosis should be based on clinical symptoms, endoscopic appearance and histologic findings. <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin">Ciprofloxacin</a><br />
 and metronidazole are the treatment of choice for pouchitis. Fistulae and perianal abscesses should be suspected to be an<br />
 expression of misdiagnosed Crohn&#8217;s disease. Strictures are confronted by endoscopic balloon dilatation. Patients who will<br />
 be refractory to all forms of medical treatment should have surgical treatment such as faecal diversion or pouch revision.</p>
<p>	Content Type Journal ArticleDOI 10.1007/s10151-010-0630-zAuthors<br />
		V. N. Papadopoulos, 1st Propedeutic Surgical Department, A.H.E.P.A University Hospital, Medi&#8230;</p>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ileal-pouch-dysfunction-2.html">Ileal pouch dysfunction</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/ileal-pouch-dysfunction-2.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Increasing trend of resistance to nalidixic acid and emerging ceftriaxone and ciprofloxacin resistance in Salmonella enterica serovar Typhimurium in Slovakia, 2005 to 2009</title>
		<link>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/increasing-trend-of-resistance-to-nalidixic-acid-and-emerging-ceftriaxone-and-ciprofloxacin-resistance-in-salmonella-enterica-serovar-typhimurium-in-slovakia-2005-to-2009-4.html</link>
		<comments>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/increasing-trend-of-resistance-to-nalidixic-acid-and-emerging-ceftriaxone-and-ciprofloxacin-resistance-in-salmonella-enterica-serovar-typhimurium-in-slovakia-2005-to-2009-4.html#comments</comments>
		<pubDate>Thu, 26 Aug 2010 07:40:18 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Ciprofloxacin]]></category>

		<guid isPermaLink="false">http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/increasing-trend-of-resistance-to-nalidixic-acid-and-emerging-ceftriaxone-and-ciprofloxacin-resistance-in-salmonella-enterica-serovar-typhimurium-in-slovakia-2005-to-2009-4.html</guid>
		<description><![CDATA[Abstract: A 5-year survey from 2005 to 2009 revealed an increasing trend of resistance to nalidixic acid (from 0% in 2005 to 11% in 2009) among 858 clinical isolates of Salmonella Typhimurium. In addition, 10 ceftriaxone-resistant and 3 Ciprofloxacin-resistant Salmonella Typhimurium isolates were detected over the period of study. (Source: Diagnostic Microbiology and Infectious Disease)
Increasing trend of resistance to nalidixic acid and emerging ceftriaxone and ciprofloxacin resistance in Salmonella enterica serovar Typhimurium in Slovakia, 2005 to 2009 is a post from: Prescription Drugs
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/increasing-trend-of-resistance-to-nalidixic-acid-and-emerging-ceftriaxone-and-ciprofloxacin-resistance-in-salmonella-enterica-serovar-typhimurium-in-slovakia-2005-to-2009-4.html">Increasing trend of resistance to nalidixic acid and emerging ceftriaxone and ciprofloxacin resistance in Salmonella enterica serovar Typhimurium in Slovakia, 2005 to 2009</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></description>
			<content:encoded><![CDATA[<p>Abstract: A 5-year survey from 2005 to 2009 revealed an increasing trend of resistance to nalidixic acid (from 0% in 2005 to 11% in 2009) among 858 clinical isolates of Salmonella Typhimurium. In addition, 10 ceftriaxone-resistant and 3 <a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin">Ciprofloxacin</a>-resistant Salmonella Typhimurium isolates were detected over the period of study. (Source: Diagnostic Microbiology and Infectious Disease)</p>
<p><a href="http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/increasing-trend-of-resistance-to-nalidixic-acid-and-emerging-ceftriaxone-and-ciprofloxacin-resistance-in-salmonella-enterica-serovar-typhimurium-in-slovakia-2005-to-2009-4.html">Increasing trend of resistance to nalidixic acid and emerging ceftriaxone and ciprofloxacin resistance in Salmonella enterica serovar Typhimurium in Slovakia, 2005 to 2009</a> is a post from: <a href="http://www.prescriptiondrugs2go.com">Prescription Drugs</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.prescriptiondrugs2go.com/popular-drug-information/c/ciprofloxacin/increasing-trend-of-resistance-to-nalidixic-acid-and-emerging-ceftriaxone-and-ciprofloxacin-resistance-in-salmonella-enterica-serovar-typhimurium-in-slovakia-2005-to-2009-4.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
